Skip to main content
. Author manuscript; available in PMC: 2014 Dec 29.
Published in final edited form as: Ann Emerg Med. 2013 Apr 6;62(4):311–318.e4. doi: 10.1016/j.annemergmed.2013.03.017

Table 2.

Change in numerical rating scale between baseline and one hour post baseline

Population Ketorolac
Median Improvement
(IQR), N
Metoclopramide +
diphenhydramine
Median Improvement
(IQR), N
95%CI for
difference
between
medians*
Non-migraine, non-cluster recurrent headache 3 (2, 6), 60 5 (3, 7), 60 0, 3
Tension-type headache 3 (2, 6), 46 5 (3, 7), 43 0, 3
*

Independent samples Hodges-Lehman estimate